Security key
03969K108
Arcutis Biotherapeutics, Inc. - Common Stock (ARQT)
CUSIP: 03969K108
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 59,389,299
- Total 13F value
- $1,134,920,691
- Share change
- +10,301,125
- Put/Call ratio
- 8.1%
- SEC-reported price per share
- $19.11
- Number of holders
- 138
- Value change
- +$194,978,652
- Number of buys
- 102
- Number of sells
- 27
- Shares outstanding
- 125,896,702
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
138
Top holders
10
ARQT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Arcutis Biotherapeutics, Inc. SEC filings
Arcutis Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03969K108
Recent filing periods:
Ownership snapshot
Top reported holders of ARQT - Arcutis Biotherapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
Frazier Life Sciences Man...
Comparable rows
0/15
Latest evidence
30 Jun 2022
13F
3/4/5
Highest disclosed value: $179,733,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Frazier Life Sciences Management, L.P. has the largest disclosed position value at $179.73M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Frazier Life Sciences Management, L.P.'s linked filing trail.
Disclosed position value
Top 5
ORBIMED ADVISORS LLC
$101.9M
Frazier Life Sciences Management,...
$179.73M
FMR LLC
$164.36M
BlackRock Finance, Inc.
$97.56M
Bain Capital Life Sciences Invest...
$63.93M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
3/4/5
Company · 10%+ Owner
|
—
denominator unverified
|
$101,897,000
4,781,646 shares
|
— | 30 Jun 2022 |
| Frazier Life Sciences Management, L.P. |
13F
Company
|
—
denominator unverified
|
$179,733,000
8,434,232 shares
|
— | 30 Jun 2022 |
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$164,357,000
7,712,680 shares
|
— | 30 Jun 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$97,561,000
4,578,153 shares
|
— | 30 Jun 2022 |
| Bain Capital Life Sciences Investors, LLC |
13F
Company
|
—
denominator unverified
|
$63,930,000
3,000,000 shares
|
— | 30 Jun 2022 |
| Point72 Asset Management, L.P. |
13F
Company
|
—
denominator unverified
|
$42,352,000
1,987,431 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
138
Shares
59,389,299
Rows available
138
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
112
Q3 2022 holders
138
Holder diff
26
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend